prostate cancer Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Male only (40)
Any (8)

Phase 0 (1)
Phase 1 (11)
Phase 1/2 (4)
Phase 2 (9)
Phase 3 (2)
Unknown (21)

Interventional (37)
Observational (9)
OBSERVATIONAL (1)

Radboud University (3)
Shenzhen Geno-Immune Medical Institute (2)
University of Washington (2)
Washington University School of Medicine (2)
Weill Medical College of Cornell University (2)
Amgen (1)
Andrei Iagaru (1)
Arcus Biosciences, Inc. (1)
AstraZeneca (1)
Bayer (1)
Brown University (1)
Celgene (1)
Chinese University of Hong Kong (1)
Dana-Farber Cancer Institute (1)
ESSA Pharmaceuticals (1)
East and North Hertfordshire NHS Trust (1)
Grupo de Investigación Clínica en Oncología Radioterapia (1)
Hoffmann-La Roche (1)
Janssen Research & Development, LLC (1)
Jonsson Comprehensive Cancer Center (1)
Luis Souhami (1)
M.D. Anderson Cancer Center (1)
Maastricht Radiation Oncology (1)
Martini-Klinik am UKE GmbH (1)
Medical College of Wisconsin (1)
Medical University of Graz (1)
Memorial Sloan Kettering Cancer Center (1)
Metro Health, Michigan (1)
Myriad Genetic Laboratories, Inc. (1)
Poseida Therapeutics, Inc. (1)
Reykjavik University (1)
Rutgers, The State University of New Jersey (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Sunnybrook Health Sciences Centre (1)
Turku University Hospital (1)
Universitaire Ziekenhuizen Leuven (1)
University of Miami (1)
University of Pennsylvania (1)
University of Virginia (1)
VA Greater Los Angeles Healthcare System (1)
Yale University (1)

No (44)
Yes (4)

No (48)

Adult (18+) (48)
Pediatric (Under 18) (4)

I am/have/had

I am/have/hadcancer

I am/have/hadprostatectomy

I am/have/hadadenocarcinoma of prostate

I am/have/hadandrogen suppression

I am/have/hadadenocarcinoma

I am/have/hadprostate specific antigen

I am/have/hadbone scan

I am/have/hadcastration-resistant prostate cancer

I am/have/hadorchiectomy

I am/have/hadmetastatic prostate cancer

I am/have/hadprostate cancer metastatic

I am/have/hadmetastasis

I am/have/hadbiopsy of prostate

I am/have/hadprogressive disease

I am/have/hadserum testosterone

I am/have/hadbrachytherapy

I am/have/hadtransrectal ultrasound

I am/have/hadexternal beam radiation therapy

I am/have/hadprostate carcinoma

I am/have/hadbilateral orchidectomy

added new label for I am/have/had

I am looking for

I am looking forandrogens

I am looking forantiandrogen therapy

I am looking fortestosterone

I am looking forgonadorelin

I am looking forhormone therapy

I am looking forendocrine therapy

I am looking forantiandrogens

I am looking forbicalutamide

I am looking fordocetaxel

I am looking forabiraterone

I am looking forluteinizing hormone-releasing hormone agonist

I am looking forenzalutamide

I am looking forprednisone

I am looking forluteinizing hormone

I am looking fordiphosphonates

I am looking forcabazitaxel

I am looking forapalutamide

I am looking forhbed-cc

I am looking forgonadotropin

I am looking forpalb2

added new label for I am looking for

Advanced Filters

Found 2624 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

A Study Evaluating The Safety Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

A study evaluating the safety, preliminary efficacy and pharmacokinetics of ipatasertib in combination with atezolizumab and docetaxel in participants with mCRPC previously treated with second-generation AR (Androgen Receptor)-targeted therapy. The study consists of two parts: [1] Part A: Safety run-in cohort of approximately 12 participants; [2] Part B: Expansion cohort …

gnrh

lymphadenopathy

metastatic hormone refractory prostate cancer

medical castration

testosterone

0 views
16 Feb, 2024
18 locations

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
For Males
Recruiting

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

The intention of the study is to demonstrate that in participants with mHSPC, the combination of capivasertib plus abiraterone (+prednisone/prednisolone) plus ADT is superior to placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC characterised by PTEN deficiency with respect to radiographic progression-free survival (rPFS) per 1) Response Evaluation …

steroid therapy

antiandrogen therapy

bone metastases

bone lesion

prostate cancer